Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis

Yukio NAKAMURA, Takako SUZUKI, Hideshi YAMAZAKI, Hiroyuki KATO

DOI: 10.5606/ArchRheumatol.2018.6366

Issue: Volume 33 - Issue 2 - June 2018
3694 4750

Tofacitinib Induced Psoriasiform Lesion in a Patient With Rheumatoid Arthritis

Kemal Erol, Ragıp Ertaş

DOI: 10.46497/ArchRheumatol.2020.7541

Issue: Volume 35 - Issue 3 - September 2020
2035 2960

The Effects of Tofacitinib-Mediated Janus Kinase/Signal Transducers and Activators of the Transcription Signal Pathway Inhibition on Collagen Biosynthesis in Hepatic and Skin Fibroblast Cell Culture

Mehtap ŞAHİN, Hüseyin AYDIN, Ahmet ALTUN, Mehmet Emin DERİN, Ali ŞAHİN

DOI: 10.46497/ArchRheumatol.2020.7568

Issue: Volume 35 - Issue 3 - September 2020
2604 2163

Therapeutic Effects of Tofacitinib on Pristane-Induced Murine Lupus

Jiayi LIN, Yaqin ZHANG, Meihua WANG, Yang ZHANG, Pin LI, Yingping CAO, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2022.8252

Issue: Volume 37 - Issue 2 - June 2022
2115 2681